A further study in cancer patient established that the genotypes or allelic frequencies of various UGT2B7 polymorphisms were not significantly (p > 0.5) associated with responders or non-responders [34], with no association between genotype and the serum concentrations of morphine or its metabolites [34]. The gene discussed is UGT2B7; the disease is cancer.